Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Devilee

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Gene|August 6, 1999
Genomic structure of the human PLZF geneE M van Schothorst, D E Prins, B E Baysal, et al.
European Journal of Human Genetics : EJHG|January 1, 1996
Confinement of PGL, an imprinted gene causing hereditary paragangliomas, to a 2-cM interval on 11q22-q23 and exclusion of DRD2 and NCAM as candidate genesE M van Schothorst, J C Jansen, A F Bardoel, et al.
American Journal of Human Genetics|March 21, 2000
ATM-heterozygous germline mutations contribute to breast cancer-susceptibilityA Broeks, J H Urbanus, A N Floore, et al.
Genes, Chromosomes & Cancer|June 8, 2001
Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD geneP E Taschner, J C Jansen, B E Baysal, et al.
Cancer Research|August 1, 1994
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutationsR S Cornelis, M van Vliet, C B Vos, et al.
European Journal of Human Genetics : EJHG|July 21, 2001
Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testingL Lodder, P G Frets, R W Trijsburg, et al.
Lancet (London, England)|July 8, 2000
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutationE J Meijers-Heijboer, L C Verhoog, C T Brekelmans, et al.
Journal of Medical Genetics|February 27, 2004
Extending the p16-Leiden tumour spectrum by respiratory tract tumoursR A Oldenburg, W H de Vos tot Nederveen Cappel, M van Puijenbroek, et al.
British Journal of Cancer|June 12, 2014
Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapyM Kriege, A Hollestelle, A Jager, et al.
Journal of Medical Genetics|December 14, 1999
Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working GroupL N Lodder, P G Frets, R W Trijsburg, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Gene|August 6, 1999
Genomic structure of the human PLZF geneE M van Schothorst, D E Prins, B E Baysal, et al.
European Journal of Human Genetics : EJHG|January 1, 1996
Confinement of PGL, an imprinted gene causing hereditary paragangliomas, to a 2-cM interval on 11q22-q23 and exclusion of DRD2 and NCAM as candidate genesE M van Schothorst, J C Jansen, A F Bardoel, et al.
American Journal of Human Genetics|March 21, 2000
ATM-heterozygous germline mutations contribute to breast cancer-susceptibilityA Broeks, J H Urbanus, A N Floore, et al.
Genes, Chromosomes & Cancer|June 8, 2001
Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD geneP E Taschner, J C Jansen, B E Baysal, et al.
Cancer Research|August 1, 1994
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutationsR S Cornelis, M van Vliet, C B Vos, et al.
European Journal of Human Genetics : EJHG|July 21, 2001
Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testingL Lodder, P G Frets, R W Trijsburg, et al.
Lancet (London, England)|July 8, 2000
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutationE J Meijers-Heijboer, L C Verhoog, C T Brekelmans, et al.
Journal of Medical Genetics|February 27, 2004
Extending the p16-Leiden tumour spectrum by respiratory tract tumoursR A Oldenburg, W H de Vos tot Nederveen Cappel, M van Puijenbroek, et al.
British Journal of Cancer|June 12, 2014
Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapyM Kriege, A Hollestelle, A Jager, et al.
Journal of Medical Genetics|December 14, 1999
Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working GroupL N Lodder, P G Frets, R W Trijsburg, et al.
Pageof 12